{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-275207","form_type":"8-K/A","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.319813+00:00","generated_at":"2026-06-08T05:00:14.107112+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Coherus completes Surface Oncology acquisition, files Surface's financials on 8-K/A","bullets":["Merger closed Sep 8, 2023; Surface became wholly owned subsidiary after two-step merger.","Unaudited condensed financial statements of Surface for H1 2023 and 2022 now filed on this amendment.","Financial statements incorporated from Surface's Q2 2023 10-Q filed Aug 2, 2023.","Original 8-K filed Sep 8, 2023 reported the closing; this amendment adds required financials."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-275207","json":"https://secwatch.observer/filing/0001193125-23-275207.json","markdown":"https://secwatch.observer/filing/0001193125-23-275207.md","text":"https://secwatch.observer/filing/0001193125-23-275207.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000119312523275207/0001193125-23-275207-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000119312523275207/d514976d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:00:14.107112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}